期刊： RADIOTHERAPY AND ONCOLOGY, 2023; 181 ()
Background and purpose: We aimed to assess if radiation dose escalation to either the whole primary tumour, or to an 18F-FDG-PET defined subvolume wit......
期刊： RADIOTHERAPY AND ONCOLOGY, 2023; 183 ()
Aim: To identify risk factors for self-reported cognitive impairment in radically treated stage III non-small cell lung cancer (NSCLC). Methods: Cogni......
